Colonoscopy Techniques for Inflammatory Bowel Disease
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial compares two colonoscopy techniques to determine which better detects early cancer signs in individuals with Inflammatory Bowel Disease (IBD). The trial evaluates the use of a dye spray during the procedure (Dye Spraying Chromocolonoscopy) versus a high-definition camera (High Definition Colonoscopy). It targets individuals who have had IBD affecting their colon for at least eight years or have a liver condition called primary sclerosing cholangitis. Participants should not have a history of colon cancer or have undergone a colonoscopy in the last six months. The aim is to identify the most effective method for early detection of potentially harmful changes in the colon. As an unphased trial, this study allows participants to contribute to significant research that could enhance early cancer detection methods for those with IBD.
Do I need to stop my current medications for this trial?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
What prior data suggests that these colonoscopy techniques are safe for detecting neoplastic lesions in IBD patients?
Research has shown that both dye spraying chromo-colonoscopy and high-definition white light colonoscopy are safe for patients with inflammatory bowel disease (IBD). Studies have found no major differences in safety between these two methods, indicating that neither causes more side effects or complications than the other.
Dye spraying chromo-colonoscopy uses a special dye to highlight areas of the colon, helping doctors see any abnormal parts more clearly. It is easy to learn and helps identify certain changes in the colon. High-definition white light colonoscopy uses a camera with very clear images to detect changes. Both methods are effective and generally comfortable for patients, without causing major issues.
Prospective trial participants can feel reassured by the research. Both methods are standard and have been safely used for many years to check for colon cancer in people with long-term IBD.12345Why are researchers excited about this trial?
Researchers are excited about these colonoscopy techniques for Inflammatory Bowel Disease (IBD) because they promise to enhance detection capabilities. Unlike standard colonoscopy, Dye Spraying Chromocolonoscopy uses a special dye to highlight subtle changes in the colon's lining, potentially revealing abnormalities that might otherwise go unnoticed. On the other hand, High Definition Colonoscopy offers sharper and more detailed images, increasing the chances of spotting problematic areas. By improving visualization, these methods could lead to better diagnosis and management of IBD, ultimately improving patient outcomes.
What evidence suggests that these colonoscopy techniques are effective for detecting neoplastic lesions in patients with long-standing IBD?
This trial will compare dye-spraying chromocolonoscopy with high-definition white light colonoscopy for monitoring inflammatory bowel disease (IBD). Research has shown that dye-spraying chromocolonoscopy might better detect abnormal cells that can lead to cancer in people with IBD. Studies have found it more effective than high-definition white light colonoscopy in spotting these abnormal areas. However, both methods offer advantages. High-definition colonoscopy alone has detected more abnormal cells compared to older techniques. For some, high-definition white light colonoscopy is a practical choice because it effectively finds new, abnormal tissue growth. Overall, evidence supports using both dye-spraying chromocolonoscopy and high-definition colonoscopy for monitoring IBD.16789
Are You a Good Fit for This Trial?
This trial is for adults over 18 with a history of Ulcerative Colitis, Crohn's disease affecting the colon, or unclassified colitis lasting at least eight years, or any duration if also diagnosed with primary sclerosing cholangitis. Participants must have significant colon involvement and not had a total colectomy or recent colonoscopy.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants undergo either High Definition White Light Colonoscopy (HDWLC) with biopsies every 10 cm or Dye Spraying Chromo-colonoscopy (DSC) based on randomization
Follow-up
Participants are monitored for safety and effectiveness after the colonoscopy procedure
What Are the Treatments Tested in This Trial?
Interventions
- Dye Spraying Chromocolonoscopy
- High Definition Colonoscopy
Find a Clinic Near You
Who Is Running the Clinical Trial?
Beth Israel Deaconess Medical Center
Lead Sponsor